Unassociated Document


    EXHIBIT
10.43

    EMPLOYMENT
AGREEMENT

    


    This EMPLOYMENT AGREEMENT, dated
December 14, 2009 (the “Agreement”), is made
and entered into by and between NexMed, Inc., a Nevada corporation (the “Company”), and Bassam
Damaj, Ph.D. (the “Executive”).

    


    WHEREAS, the Company desires to employ
Executive and to enter into this Agreement in connection with the Company’s
acquisition of Bio-Quant, Inc. pursuant to that certain Agreement and Plan of
Merger by and among the Company, BQ Acquisition Corp., Bio-Quant, Inc. and
certain other parties thereto (the “Merger
Agreement”);

    


    WHEREAS, the Company considers it
essential to its best interests and the best interests of its stockholders for
the Company to employ Executive during the term of this Agreement;
and

    


    WHEREAS, Executive is willing to accept
his employment with the Company on the terms hereinafter set forth in this
Agreement.

    


    NOW, THEREFORE, in consideration of the
premises and mutual covenants herein and for other good and valuable
consideration, the parties agree as follows:

    


    
      	
              1.

            	
              Term of
      Employment.  Subject to the terms and conditions set
      forth in Section 6 of this Agreement, Executive’s employment with the
      Company shall be “at will,” and the Company and Executive shall each have
      the right to terminate Executive’s employment hereunder.  The
      term of Executive’s employment hereunder is referred to herein as the
      “Employment
      Term.”

            


    

     

    
      	
              2.

            	
              Position.

            


    

     

    
      	
               
      

            	
              (a)

            	
              During
      the Employment Term, Executive shall be employed by the Company as
      President and Chief Executive Officer, and shall have such duties,
      authority, and responsibility as are commensurate with his position,
      subject to the direction of the Company’s Board of Directors (the “Board”).

            


    

     

    
      	
               
      

            	
              (b)

            	
              During
      the Employment Term, Executive shall devote all of his business time and
      attention to the performance of his duties hereunder faithfully and to the
      best of his abilities and shall not undertake employment with, or
      participate in, the conduct of the business affairs of any other person,
      corporation, or entity; provided, that nothing
      shall preclude Executive from (i) with the prior approval of the Board,
      serving as a director, trustee or member of another business organization
      or (ii) participating in the affairs of any recognized charitable
      organizations, or in any community affairs, of Executive’s
      choice.

            


    

     

    
      	
               
      

            	
              (c)

            	
              Executive’s
      duties hereunder shall be performed for the Company worldwide, with
      principal business activities expected to be at the Company’s offices in
      East Windsor, New Jersey and/or San Diego,
  California.

            


    


    
      
         


      

      
         


        
          

        

      

      
         


      

    

     

    
      	
              3.

            	
              Compensation.

            


    

     

    
      	
               
      

            	
              (a)

            	
              Base
      Salary.  During the Employment Term, the Company shall
      pay Executive a base salary, subject to increase at the discretion of the
      Board, at the initial annual rate of $300,000 (the “Base Salary”),
      payable in regular installments in accordance with the Company’s usual
      payroll practices.

            


    

     

    
      	
               
      

            	
              (b)

            	
              Annual
      Bonus.  With respect to each calendar year during the
      Employment Term, Executive shall be eligible to earn an annual bonus award
      (the “Bonus”) in an
      amount not to exceed 65% of Executive’s annual Base Salary.  The
      amount of the Bonus shall be determined by the Board, or the Compensation
      Committee of the Board (the “Compensation
      Committee”), in its sole discretion, based upon the achievement by
      the Company of objective performance measures established and determined
      by the Board or the Compensation Committee in consultation with Executive
      no later than the end of the first month of such calendar year; it is
      agreed that one of such objective performance measures shall be the
      payment to Executive of a bonus of $100,000 each year for every $1 million
      in revenue growth realized through non-acquisition and non-licensing
      activities achieved during such year.  The Bonus, if any, with
      respect to each calendar year in the Employment Term shall be paid as
      promptly as practicable following the delivery of the Company’s audited
      financial statements for such year, but not later than March 15 of the
      calendar year following the calendar year for which the Bonus is
      payable.  Unless otherwise stated herein, the Bonus shall not
      accrue until the date on which it is paid, and Executive must be employed
      on the date the Bonus is paid in order to receive the
    Bonus.

            


    

     

    
      	
               
      

            	
              (c)

            	
              Stock Option Grant;
      Equity Awards.

            


    

     

    
      	
               
      

            	
              (i)

            	
              Subject
      to approval by the Board or the Compensation Committee and subject to
      stockholder approval of an increase in the number of shares authorized for
      issuance under the Company’s 2006 Stock Incentive Plan, the Company shall
      grant to Executive an award for 1,500,000 shares of restricted stock (the
      “Award”).
      The Award shall vest with respect to 300,000 shares on the first
      anniversary of employment, 500,000 shares on the second anniversary of
      employment and the remaining 700,000 shares on the third anniversary of
      employment.  All unvested shares underlying the Award shall vest
      immediately upon (i) a “Change in Control,” as defined in Appendix A, (ii)
      Executive’s termination without Cause pursuant to Section 6(c) or (iii)
      Executive’s resignation for Good Reason pursuant to Section
      6(d).

            


    

     

    
      	
               
      

            	
              (ii)

            	
              In
      addition, the Compensation Committee shall consider annually whether to
      grant any equity-based compensation awards to the Executive in accordance
      with the terms and subject to the conditions of the Company’s equity
      compensation plans.

            


    


    
      
         


      

      
        2

        
          

        

      

      
         


      

    

     

    
      	
              4.

            	
              Employee
      Benefits.  During the Employment Term, Executive shall be
      eligible for inclusion, to the extent permitted by law, as a full-time
      employee of the Company or any of its subsidiaries, in any and all of the
      following plans, programs, and policies in effect at the time: (i)
      pension, profit sharing, savings, and other retirement plans and programs,
      (ii) life and health (medical, dental, hospitalization, short-term and
      long-term disability) insurance plans and programs, (iii) stock option and
      stock purchase plans and programs, (iv) accidental death and dismemberment
      protection plans and programs, (v) travel accident insurance plans and
      programs, (vi) vacation policy (Executive shall have six weeks of paid
      vacation per calendar year), and (vii) other plans and programs sponsored
      by the Company or any subsidiary for employees or executives generally,
      including any and all plans and programs that supplement any or all of the
      foregoing types of plans or programs.  Nothing in this Agreement
      shall preclude the Company or any of its subsidiaries or affiliates from
      terminating or amending any employee benefit plan or program from time to
      time after the date of this
Agreement.

            


    

     

    
      	
              5.

            	
              Business Expenses and
      Perquisites.  The Company shall reimburse to Executive,
      or pay directly, all reasonable expenses incurred by Executive in
      connection with the business of the Company, and its subsidiaries and
      affiliates, including but not limited to business-class travel, reasonable
      accommodations, and entertainment, subject to documentation in accordance
      with the Company’s policy.

            


    

     

    
      	
              6.

            	
              Termination.  Subject
      to this Section 6, either party may terminate this Agreement at any time
      and from time to time.  In the event of the termination of
      Executive’s employment, the Employment Term shall end on the day of such
      termination.

            


    

     

    
      	
               
      

            	
              (a)

            	
              By the Company for
      Cause. The Company may, for Cause, terminate Executive’s employment
      hereunder at any time by written notice to Executive.  For
      purposes of this Agreement, the term “Cause” shall
      mean Executive’s (i) engaging in fraud against the Company or
      misappropriation of funds of the Company, (ii) disregard or failure to
      follow specific and reasonable directives of the Board, (iii) willful
      failure to perform his duties as President and Chief Executive Officer of
      the Company, (iv) willful misconduct resulting in material injury to the
      Company, (v) violation of the terms of the Confidential Information and
      Intellectual Property Agreement between Executive the Company referred to
      in Section 11 below, (vi) conviction of, or Executive’s plea of guilty or
      no contest to, a felony or any crime involving as a material element fraud
      or dishonesty, or (vii) material breach (not covered by clauses (i)
      through (vi) of this paragraph) of any of the other provisions of this
      Agreement; provided, that, in the case of subclauses (ii), (iii) or (vii),
      Cause shall not exist if the act or omission deemed to constitute Cause is
      cured (if curable) by Executive within thirty (30) days after written
      notice thereof to Executive by the Company.  For purposes of the
      foregoing, no act, or failure to act, on Executive’s part shall be
      considered “willful” unless done, or omitted to be done, by Executive
      other than in good faith, and without reasonable belief that his action or
      omission was in furtherance of the interests of the
    Company.

            


    


    
      
         


      

      
        3

        
          

        

      

      
         


      

    


    In the
event of the termination of Executive’s employment under this Section 6(a) for
Cause, the Employment Term shall end on the day of such termination and the
Company shall pay to Executive, no later than the payroll cycle following
Executive’s termination, in one lump sum: (i) any accrued but unpaid Base
Salary, less applicable deductions, including salary in respect of any accrued
and accumulated vacation due to Executive at the date of such termination; and
(ii) any amounts owing, but not yet paid, pursuant to Section 5
hereof.

     

    Except as
specifically set forth in Section 9 hereof, the Company shall have no further
obligations to Executive under this Agreement.

     

    
      	
               
      

            	
              (b)

            	
              Disability or
      Death.  If Executive should suffer a Permanent
      Disability, the Company may terminate Executive’s employment hereunder
      upon ten (10) or more days’ prior written notice to
      Executive.  If Executive should pass away during the term of
      this Agreement, Executive’s employment shall be deemed terminated on his
      date of death.  For purposes of this Agreement, a “Permanent
      Disability” shall be deemed to have occurred only when Executive has
      qualified for benefits (including satisfaction of any applicable waiting
      period) under the Company’s or a subsidiary’s long-term disability
      insurance arrangement.  In the event of the termination of
      Executive’s employment hereunder by reason of Permanent Disability or
      death, the Employment Term shall end on the day of such termination and
      the Company shall pay, no later than the payroll cycle following
      Executive’s termination, to Executive or Executive’s legal representative
      (in the event of Permanent Disability), or any beneficiary or
      beneficiaries designated by Executive to the Company in writing, or to
      Executive’s estate if no such beneficiary has been so designated (in the
      event of Executive’s death), a single lump sum payment of: (i) any accrued
      but unpaid Base Salary, less applicable deductions, including salary in
      respect of any accrued and accumulated vacation, due to Executive at the
      date of such termination; (ii) any amounts owing, but not yet paid,
      pursuant to Section 5 hereof.

            


    

     

    In
addition, upon a termination under this Section 6(b), and upon the satisfaction
of the conditions set forth herein: (1) Executive shall receive a pro rata Bonus
for the calendar year in which such termination occurs, equal to the Bonus he
would have received, to the extent all criteria for such a Bonus have been met
(with the exception of the requirement that Executive be employed on the date
the Bonus is to be paid), for the calendar year of said termination multiplied
by a fraction, the numerator of which is the number of days in such year
preceding and including the date of termination, and the denominator of which is
365.  Said pro-rata Bonus shall be paid at the same time as the Bonus
would have been paid had Executive remained employed by the Company through the
date of payment, but in any event, not later than March 15 of the calendar year
following the calendar year for which the Bonus is payable; (2) Executive shall
receive any unpaid Bonus for the calendar year preceding his termination, to the
extent that all criteria for such bonus have been met (with the exception of the
requirement that Executive be employed on the date the Bonus is to be
paid).  Said Bonus shall be paid at the same time as the Bonus would
have been paid had Executive remained employed by the Company through the date
of payment; and (3) all of Executive’s outstanding but unvested equity awards
granted pursuant to Section 3(c) of this Agreement shall vest
immediately.  The payment of any Bonus pursuant to clause (1) or
clause (2) above and the acceleration of Executive’s options and stock pursuant
to clause (3), are conditioned upon Executive (or his legal representative)
signing a release in favor of the Company, as provided for in Section
6(f).


    
      
         


      

      
        4

        
          

        

      

      
         


      

    

     

    
      	
               
      

            	
              (c)

            	
              By the Company without
      Cause.  The Company may, without Cause, terminate
      Executive’s employment hereunder at any time upon ten (10) or more days’
      written notice to Executive.  The Company, in its sole
      discretion, may provide the Executive with ten (10) days’ pay in lieu of
      notice.  In the event Executive’s employment is terminated
      pursuant to this Section 6(c), the Employment Term shall end on the day of
      such termination and the Company shall pay to Executive, no later than the
      payroll cycle following Executive’s termination, in one lump sum: (i) any
      accrued but unpaid Base Salary, less applicable deductions, including
      salary in respect of any accrued and accumulated vacation, due to
      Executive at the date of such termination, and (ii) any amounts owing, but
      not yet paid, pursuant to Section 5
hereof.

            


    

     

    In
addition, upon a termination under this Section 6(c) and upon the satisfaction
of the conditions set forth herein: (1) Executive shall receive a pro rata Bonus
for the calendar year in which such termination occurs, equal to the Bonus he
would have received, to the extent all criteria for such a Bonus have been met
(with the exception of the requirement that Executive be employed on date the
Bonus is to be paid), for the calendar year of said termination multiplied by a
fraction, the numerator of which is the number of days in such year preceding
and including the date of termination, and the denominator of which is
365.  Said pro-rata Bonus shall be paid at the same time as the Bonus
would have been paid had Executive remained employed by the Company through the
date of payment, but in any event, not later than March 15 of the calendar year
following the calendar year for which the Bonus is payable; (2) Executive shall
receive any unpaid Bonus for the calendar year preceding his termination, to the
extent that all criteria for such bonus have been met (with the exception of the
Executive being employed on the date the Bonus is to be paid).  Said
Bonus shall be paid at the same time as the Bonus would have been paid had
Executive remained employed by the Company through the date of payment; (3) all
of Executive’s outstanding but unvested equity awards granted pursuant to
Section 3(c) of this Agreement shall vest immediately; and (4) the Company shall
pay Executive an amount equal to twelve months of Executive’s
Base Salary at the time of such termination (the “Severance”).  The
payment of any Bonus pursuant to clause (1) or clause (2) above and the
acceleration of Executive’s options and stock pursuant to clause (3), are
conditioned upon Executive signing a release in favor of the Company, as
provided for in Section 6(f), and the Severance shall be payable in a single
lump sum within 60 days after the effective date of termination of the
Employment Term, subject to Executive’s execution, delivery and non-revocation
of a release in favor of the Company, as provided for in Section
6(f).


    
      
         


      

      
        5

        
          

        

      

      
         


      

    

     

    Except as
specifically set forth in Section 9 hereof, the Company shall have no further
obligations to Executive under this Agreement.

     

    
      	
               
      

            	
              (d)

            	
              Resignation by
      Executive for Good Reason. If any of the events described below
      occurs during the Employment Term, Executive may terminate Executive’s
      employment hereunder for Good Reason by written notice to the Company
      identifying the event or omission constituting Good Reason not more than
      one (1) month following the occurrence of such event and, in the case of
      subclauses (ii), (iii), or (iv) below, a failure by the Company to cure
      such act or omission within thirty (30) days after receipt of such written
      notice.  In the event that Executive elects to terminate
      employment pursuant to this Section 6(d), the Employment Term and
      Executive’s employment hereunder will be terminated effective as of the
      later of thirty-one (31) days after the Company’s receipt of Executive’s
      notice of termination or thirty-one (31) days after the event, and
      Executive’s resignation for Good Reason pursuant to this Section 6(d)
      shall be treated for all purposes as a termination without Cause pursuant
      to Section 6(c) and the provisions of Section 6(c) shall apply to such
      termination, including the payment of Severance.  The occurrence
      of any of the following events without Executive’s consent shall permit
      Executive to terminate Executive’s employment for “Good Reason” pursuant
      to this Section 6(d):

            


    

     

    
      	
               
      

            	
              (i)

            	
              A
      “Change in Control” (as defined in Appendix A
      attached hereto) occurs;

            


    

     

    
      	
               
      

            	
              (ii)

            	
              The
      failure by the Company to observe or comply in any material respect with
      any of the material provisions of this
  Agreement;

            


    

     

    
      	
               
      

            	
              (iii)

            	
              A
      material diminution in Executive’s
duties;

            


    

     

    
      	
               
      

            	
              (iv)

            	
              The
      assignment to Executive of duties that are materially inconsistent with
      Executive’s duties or that materially impair Executive’s ability to
      function as the President and Chief Executive Officer of the Company;
      or

            


    

     

    
      	
               
      

            	
              (v)

            	
              The
      relocation of Executive’s primary office from a location that is more than
      50 miles from both (a) the Company’s executive office that constitutes
      Executive’s primary office location at the time of relocation and (b)
      Executive’s primary residence at the time of such
    relocation.

            


    

     

    Except as
specifically set forth in Section 9 hereof, the Company shall have no further
obligations to Executive under this Agreement.

    


    
      	
               
      

            	
              (e)

            	
              By Executive without
      Good Reason.  Executive may terminate the Employment Term
      and Executive’s employment hereunder at any time without Good Reason upon
      thirty (30) days advance written notice to the Company.  In the
      event Executive’s employment is terminated pursuant to this Section 6(e),
      the Company shall pay to Executive, no later than ten (10) days after the
      last day of Executive’s employment, in one lump sum, the sum of (i) any
      accrued but unpaid Base Salary, less applicable deductions, including
      salary in respect of any accrued and accumulated vacation, due to
      Executive at the date of such termination, and (ii) any amounts owing, but
      not yet paid, pursuant to Section 5
hereof.

            


    


    
      
         


      

      
        6

        
          

        

      

      
         


      

    

     

    Except as
specifically set forth in Section 9 hereof, the Company shall have no further
obligations to Executive under this Agreement.

     

    
      	
               
      

            	
              (f)

            	
              Release.  Notwithstanding
      any other provision of this Agreement to the contrary, Executive
      acknowledges and agrees that any and all payments and benefits to which
      Executive is entitled under Section 6(b), 6(c) or 6(d), with the exception
      of accrued salary, accrued vacation payments, and payments pursuant to
      Section 5 of this Agreement, are conditioned upon and subject to
      Executive’s first executing a general waiver and release (and the
      expiration of any associated revocation period), in such reasonable and
      customary form as shall be prepared by the Company, of all claims
      Executive may have against the Company, and related entities and
      individuals. 

            


    

     

    
      	
              7.

            	
              Required Postponement
      for Specified Executives.

            


    

     

    
      	
               
      

            	
              (a)

            	
              Specified Executive
      Delay.  Notwithstanding anything in this Agreement to the
      contrary, if required by section 409A of the Internal Revenue Code of
      1986, as amended (the “Code”) and if
      Executive is considered a Specified Executive (as defined herein) and
      payment of any amounts under this Agreement is required to be delayed for
      a period of six months after separation from service pursuant to Section
      409A of the Code, payment of such amounts shall be delayed as required by
      section 409A, and the accumulated amounts shall be paid in a lump sum
      payment within five days after the end of the six-month
      period.  If Executive dies during the postponement period prior
      to the payment of benefits, the amounts withheld on account of section
      409A shall be paid to the personal representative of Executive’s estate
      within 60 days after the date of Executive’s
  death.

            


    

     

    
      	
               
      

            	
              (b)

            	
              “Specified
      Executive” shall mean an employee who, at any time during the
      12-month period ending on the identification date, is a “specified
      employee” under section 409A of the Code, as determined by the
      Compensation Committee of the Board or its delegate.  The
      determination of Specified Executives, including the number and identity
      of persons considered officers and the identification date, shall be made
      by the Compensation Committee or its delegate in accordance with the
      provisions of section 409A of the Code and the regulations issued
      thereunder.

            


    

     

    
      	
              8.

            	
              No Mitigation;
      Employee Benefit Plans.  Executive shall not be required
      to mitigate amounts payable to him under this Agreement by seeking other
      employment or otherwise, and there shall be no offset against amounts
      payable to Executive under this Agreement on account of Executive’s
      subsequent employment.  Amounts payable to Executive under this
      Agreement shall not be offset by any claims that the Company may have
      against Executive, and such amounts payable to Executive under this
      Agreement shall not be affected by any other circumstances, including,
      without limitation, any counterclaim, recoupment, defense, or other right
      that the Company may have against Executive or others; provided, however, that
      payments made to Executive as a result of the termination of Executive’s
      employment hereunder shall not be considered as includible compensation
      with respect to any employee benefit plans maintained by the Company,
      except to the extent otherwise required by
law.

            


    


    
      
         


      

      
        7

        
          

        

      

      
         


      

    

     

    
      	
              9.

            	
              Indemnification.  In
      the event that Executive is made a party or threatened to be made a party
      to any action, suit, or proceeding, whether civil, criminal,
      administrative, or investigative (a “Proceeding”),
      by reason of Executive’s employment with, or serving as an officer of, the
      Company, the Company shall indemnify and hold Executive harmless, and
      defend Executive to the fullest extent authorized by the laws of the state
      in which the Company is incorporated, as the same exist and may hereafter
      be amended, against any and all claims, demands, suits, judgments,
      assessments, and settlements (collectively the “Claims”),
      including all expenses incurred or suffered by Executive in connection
      therewith (excluding, however, any legal fees incurred by Executive for
      Executive’s own counsel, except as otherwise provided in this Section 9,
      and excluding any Proceedings initiated by executive), and such
      indemnification shall continue as to Executive even after Executive is no
      longer employed by the Company hereunder, and shall inure to the benefit
      of Executive’s heirs, executors, and administrators; provided, however, that
      Executive promptly gives written notice to the Company of any such Claims
      (although Executive’s failure to promptly give notice shall not affect the
      Company’s obligations under this Section 9 except to the extent that such
      failure prejudices the Company or its ability to defend such
      Claims).  The Company shall have the right to undertake, with
      counsel or other representatives of its own choosing, the defense or
      settlement of any Claims.  In the event that the Company shall
      fail to notify Executive, within ten days of its receipt of Executive’s
      written notice, that the Company has elected to undertake such defense or
      settlement, or if at any time the Company shall otherwise fail to
      diligently defend or pursue settlement of such Claims, then Executive
      shall have the right to undertake the defense, compromise, or settlement
      of such Claims, in which event the Company shall hold Executive harmless
      from any legal fees incurred by Executive for Executive’s
      counsel.  Neither Executive nor the Company shall settle any
      Claims without the prior written consent of the other, which consent shall
      not be unreasonably withheld or delayed.  In the event that the
      Company submits to Executive a bona fide settlement offer from the
      claimant of Claims (which settlement offer shall include as an
      unconditional term thereof the giving by the claimant or the plaintiff to
      Executive a release from all liability in respect of such Claims), and
      Executive refuses to consent to such settlement, then thereafter the
      Company’s liability to Executive for indemnification hereunder with
      respect to such Claims shall not exceed the settlement amount included in
      such bona fide settlement offer, and Executive shall either assume the
      defense of such Claims or pay the Company’s attorneys’ fees and other
      out-of-pocket costs incurred thereafter in continuing the defense of such
      Claims.  Regardless of which party is conducting the defense of
      any such Claims, the other party, with counsel or other representatives of
      its own choosing and at its sole cost and expense, shall have the right to
      consult with the party conducting the defense of such Claims and its
      counsel or other representatives concerning such Claims and Executive and
      the respective counsel or other representatives shall cooperate with
      respect to such Claims.  The party conducting the defense of any
      such Claims and its counsel shall in any case keep the other party and its
      counsel (if any) fully informed as to the status of such Claims and any
      matters relating thereto.  Executive and the Company shall
      provide to the other such records, books, documents, and other materials
      as shall reasonably be necessary for each to conduct or evaluate the
      defense of any Claims, and will generally cooperate with respect to any
      matters relating thereto.  This Section 9 shall remain in effect
      after this Agreement is terminated, regardless of the reasons for such
      termination.  The indemnification provided to Executive pursuant
      to this Section 9 shall not supersede or reduce any indemnification
      provided to Executive under any separate agreement, or the By-Laws of the
      Company; in this regard, it is intended that this Agreement shall expand
      and extend Executive’s rights to receive
  indemnification.

            


    


    
      
         


      

      
        8

        
          

        

      

      
         


      

    

     

    
      	
              10.

            	
              Withholding.  The
      Company shall have the right to deduct and withhold from all payments to
      Executive hereunder all payroll taxes, income tax withholding and other
      federal, state and local taxes and charges which currently are or which
      hereafter may be required by law to be so deducted and
      withheld.

            


    

     

    
      	
              11.

            	
              Additional
      Agreements.  As a condition to his employment hereunder,
      Executive shall execute and deliver to the Company a Confidential
      Information and Intellectual Property Agreement in the form attached
      hereto as Exhibit A,
      which shall be incorporated herein by
reference.

            


    

     

    
      	
              12.

            	
              Non-Assignability.  Executive’s
      rights and benefits hereunder are personal to Executive, and shall not be
      alienated, voluntarily or involuntarily assigned, or
      transferred.

            


    

     

    
      	
              13.

            	
              Binding
      Effect.  This Agreement shall be binding upon the parties
      hereto, and their respective assigns, successors, executors,
      administrators, and heirs.  In the event the Company becomes a
      party to any merger, consolidation, or reorganization, this Agreement
      shall remain in full force and effect as an obligation of the Company or
      its successor(s) in interest.  None of the payments provided for
      by this Agreement shall be subject to seizure for payment of any debts or
      judgments against Executive or Executive’s beneficiary or beneficiaries,
      nor shall Executive or any such beneficiary or beneficiaries have any
      right to transfer or encumber any right or benefit
    hereunder.

            


    

     

    
      	
              14.

            	
              Entire Agreement;
      Modification.

            


    

     

    
      	
               
      

            	
              (a)

            	
              This
      Agreement supersedes all prior agreements between the Company and
      Executive relating to the subject matter hereof, with the exception of the
      Confidential Information and Intellectual Property
      Agreement.  This Agreement sets forth the entire understanding
      among the parties hereto with respect to the subject matter hereof, may
      not be changed orally, and may be changed only by an agreement in writing
      signed by the parties hereto.

            


    

     

    
      	
               
      

            	
              (b)

            	
              Executive
      acknowledges that from time to time, the Company may establish, maintain
      and distribute manuals, handbooks or personnel policies, and officers or
      other representatives of the Company may make written or oral statements
      relating to personnel policies and procedures.  Such manuals,
      handbooks and statements are intended only for general
      guidance.  No policies, procedures or statements of any nature
      by or on behalf of the Company (whether written or oral, and whether or
      not contained in any manual or handbook or personnel policies), and no
      acts or practices of any nature, shall be construed to modify this
      Agreement or to create express or implied obligations of any nature to
      Executive.

            


    


    
      
         


      

      
        9

        
          

        

      

      
         


      

    

    


    
      	
              15.

            	
              Notices.  All
      notices and communications hereunder shall be in writing, sent by
      certified or registered mail, return receipt requested, postage prepaid;
      by facsimile transmission, with proof of the time and date of receipt
      retained by the transmitter; or by hand-delivery properly
      receipted.  The actual date of receipt as shown by the return
      receipt therefore, the facsimile transmission sheet, or the hand-delivery
      receipt, as the case may be, shall determine the date on which (and, in
      the case of a facsimile, the time at which) notice was
      given.  All payments required hereunder by the Company to
      Executive shall be sent postage prepaid, or, at Executive’s election,
      shall be transferred to Executive electronically to such bank account as
      Executive may designate in writing to the Company, including designation
      of the applicable electronic address.  The foregoing items
      (other than any electronic transfer to Executive) shall be addressed as
      follows (or to such other address as the Company and Executive may
      designate in writing from time to
time):

            


    

     

    To the
Company:

    NexMed,
Inc.

    89 Twin
Rivers Drive

    East
Windsor, NJ 08520

    Fax:
609-426-9116

    Attention:
Chairman

    


    To
Executive:

    Bassam
Damaj, Ph.D.

    c/o
Bio-Quant, Inc.

    6330
Nancy Ridge Drive, Suite 103

    San
Diego, California 92121

    Fax:
1-858-866-0482

    


    
      	
              16.

            	
              Section 409A of the
      Code.  This Agreement is intended to comply with section
      409A of the Code and its corresponding regulations, to the extent
      applicable.  Accordingly, all provisions herein, or incorporated
      herein by reference, shall be construed and interpreted to comply with
      section 409A of the Code and any applicable exceptions
      thereunder.  Notwithstanding anything in this Agreement to the
      contrary, payments may only be made under this Agreement upon an event and
      in a manner permitted by section 409A of the Code, to the extent
      applicable.  As used in the Agreement, the term “termination of
      employment” shall mean Executive’s separation from service with the
      Company within the meaning of section 409A of the Code and the regulations
      promulgated thereunder.  For purposes of section 409A, the right
      to a series of payments under the Agreement shall be treated as a right to
      a series of separate payments.  Any amounts payable solely on
      account of an involuntary separation from service of Executive within the
      meaning of section 409A of the Code shall be excludible from the
      requirements of section 409A of the Code, either as involuntary separation
      pay or as short-term deferral amounts to the maximum possible
      extent.  All reimbursements and in-kind benefits provided under
      the Agreement shall be made or provided in accordance with the
      requirements of section 409A of the Code, including, where applicable, the
      requirement that (i) any reimbursement shall be for expenses incurred
      during Executive’s lifetime (or during a shorter period of time specified
      in this Agreement), (ii) the amount of expenses eligible for
      reimbursement, or in-kind benefits provided, during a calendar year may
      not affect the expenses eligible for reimbursement, or in-kind benefits to
      be provided, in any other calendar year, (iii) the reimbursement of an
      eligible expense will be made on or before the last day of the calendar
      year following the year in which the expense is incurred, and (iv) the
      right to reimbursement or in-kind benefits is not subject to liquidation
      or exchange for another
benefit.

            


    


    
      
         


      

      
        10

        
          

        

      

      
         


      

    

     

    
      	
              17.

            	
              Governing Law;
      Jurisdiction.  This Agreement shall be governed by, and
      construed and enforced according to, the domestic laws of the State of
      California without giving effect to the principles of conflict of laws
      thereof, or such principles of any other jurisdiction, which could cause
      the application of the substantive law of any jurisdiction other than the
      State of California.  The Company and Executive agree that the
      state or federal courts located in San Diego, California shall have
      exclusive jurisdiction to hear and determine any dispute which may arise
      under this Agreement.

            


    

     

    
      	
              18.

            	
              Severability.  The
      invalidity or unenforceability of any provision of this Agreement shall
      not affect the validity or enforceability of any other provision of this
      Agreement, and each other provision of the Agreement shall be severable
      and enforceable to the extent permitted by
law.

            


    

     

    
      	
              19.

            	
              Headings.  The
      headings of the Sections hereof are provided for convenience only and are
      not to serve as a basis for interpretation or construction, and shall not
      constitute a part, of this
Agreement.

            


    

     

    
      	
              20.

            	
              Signature in
      Counterparts.  This Agreement may be signed in
      counterparts, each of which shall be an original, with the same effect as
      if the signatures thereto and hereto were upon the same
      instrument.

            


    


    
      
         


      

      
        11

        
          

        

      

      
         


      

    


    IN WITNESS WHEREOF, Executive has
hereunto set his hand and the Company has caused this Agreement to be executed
in its name on its behalf, all as of the day and year first above
written.

    


    
      
        
          
            	 
      	
                    /s/
      Bassam Damaj

                  
	 
      	
                    Bassam
      Damaj, Ph.D.

                  
	 
      	 
      
	 
      	
                    NEXMED,
      INC.

                  
	 
      	 
      	 
      
	 
      	
                    By:

                  	
                    /s/
      Vivian H. Liu

                  
	 	Name:	Vivian
      H. Liu
	 
      	
                    Title:

                  	
                    Executive
      Vice
President

                  


          

        


        
          
             


          

          
             


            
              

            

          

          
             


          

        

      

       

    

    APPENDIX
A

    


    Change in
Control

    


    For the
purpose of this Agreement, a “Change in Control”
shall be deemed to have taken place if:

    


    A.
Individuals who, on the date hereof, constitute the Board (the “Incumbent Directors”)
cease for any reason to constitute at least a majority of the Board, provided
that any person becoming a director subsequent to the date hereof, whose
election or nomination for election was approved by a vote of at least
two-thirds of the Incumbent Directors then on the Board (either by a specific
vote or by approval of the proxy statement of the Company in which such person
is named as a nominee for director, without written objection to such
nomination) shall be an Incumbent Director; provided, however, that, no
individual initially elected or nominated as a director of the Company as a
result of an actual or threatened election contest with respect to directors or
as a result of any other actual or threatened solicitation of proxies or
consents by or on behalf of any person other than the Board shall be deemed to
be an Incumbent Director;

    


    B. Any
“Person” (as
such term is defined in Section 3(a)(9) of the Securities Exchange Act of 1934
(the “Exchange
Act”) and as used in Sections 13(d)(3) and 14(d)(2) of the Exchange Act)
is or becomes a “beneficial owner” (as defined in Rule 13d-3 under the Exchange
Act), directly or indirectly, of securities of the Company representing 50% or
more of the combined voting power of the Company’s then outstanding securities
eligible to vote for the election of the Board (the “Voting Securities”);
provided, however, that, the event described in this paragraph B shall not be
deemed to be a Change in Control by virtue of any of the following acquisitions:
(i) by the Company or any subsidiary of the Company in which the Company owns
more than 50% of the combined voting power of such entity (a “Subsidiary”), (ii) by
any employee benefit plan (or related trust) sponsored or maintained by the
Company or any Subsidiary, (iii) by any underwriter temporarily holding the
Company’s Voting Securities pursuant to a public offering of such Voting
Securities, (iv) pursuant to a Non-Qualifying Transaction (as defined in
paragraph C immediately below), (v) pursuant to any acquisition by Executive or
by any Person which is an “affiliate” (within the meaning of 17 C.F.R. §
230.405) of Executive (an “Excluded
Person”);

    


    C. The
consummation of a merger, consolidation, statutory share exchange or similar
form of corporate transaction involving the Company or any of its Subsidiaries
that requires the approval of the Company’s stockholders, whether for such
transaction or the issuance of securities in the transaction (a “Business
Combination”), unless immediately following such Business Combination:
(i) more than 50% of the total voting power of (A) the corporation resulting
from such Business Combination (the “Surviving
Corporation”), or (B) if applicable, the ultimate parent corporation that
directly or indirectly has beneficial ownership of 100% of the voting securities
eligible to elect directors of the Surviving Company (the “Parent Corporation”),
is represented by the Company’s Voting Securities that were outstanding
immediately prior to such Business Combination (or, if applicable, is
represented by shares into which the Company’s Voting Securities were converted
pursuant to such Business Combination), and such voting power among the holders
thereof is in substantially the same proportion as the voting power of the
Company’s Voting Securities among the holders thereof immediately prior to the
Business Combination, (ii) no Person (other than (A) any employee benefit plan
(or related trust) sponsored or maintained by the Surviving Corporation or the
Parent Corporation or (B) an Excluded Person is or becomes the beneficial owner,
directly or indirectly, of 50% or more of the total voting power of the
outstanding voting securities eligible to elect directors of the Parent
Corporation (or, if there is no Parent Corporation, the Surviving Corporation)
and (iii) at least a majority of the members of the board of directors of the
Parent Corporation (or, if there is no Parent Corporation, the Surviving
Corporation) following the consummation of the Business Combination were
Incumbent Directors at the time of the Board’s approval of the execution of the
initial agreement providing for such Business Combination (any Business
Combination which satisfies all of the criteria specified in (i), (ii) and (iii)
above shall be deemed to be a “Non-Qualifying
Transaction”);


    
      
         


      

      
         


        
          

        

      

      
         


      

    

    


    D. A sale
of all or substantially all of the Company’s assets, other than to an Excluded
Person;

    


    E. The
stockholders of the Company approve a plan of complete liquidation or
dissolution of the Company; or

    


    F. Such
other events as the Board may designate.

    


    Notwithstanding
the foregoing, a Change in Control of the Company shall not be deemed to occur
(i) solely as a result of the Closing or any of the transactions contemplated
under the Merger Agreement or (ii) solely because any person acquires beneficial
ownership of more than 50% of the Company’s Voting Securities as a result of the
acquisition of the Company’s Voting Securities by the Company which reduces the
number of the Company’s Voting Securities outstanding; provided, that, if after
such acquisition by the Company such person becomes the beneficial owner of
additional Company Voting Securities that increases the percentage of
outstanding Company Voting Securities beneficially owned by such person, a
Change in Control of the Company shall then occur.


    
      
         


      

      
         


        
          

        

      

      
         


      

    


    EXHIBIT
A

    


    CONFIDENTIALITY AND
INTELLECTUAL PROPERTY AGREEMENT

    

      NEXMED,
INC.

      


      Employee
Confidentiality and Assignment Agreement

      


      In consideration and as a condition of
my employment or continued employment by NexMed, Inc. (the “Company”), I agree as
follows:

      


      1.           Proprietary
Information.  I agree that all
information, whether or not in writing, concerning the Company’s business,
technology, business relationships or financial affairs which the Company has
not released to the general public (collectively, “Proprietary
Information”) is and will be the exclusive property of the
Company.  By way of illustration, Proprietary Information may include
information or material which has not been made generally available to the
public, such as:  (a) corporate information,
including plans, strategies, methods, policies, resolutions, negotiations or
litigation; (b) marketing
information, including strategies, methods, customer identities or other
information about customers, prospect identities or other information about
prospects, or market analyses or projections; (c) financial information,
including cost and performance data, debt arrangements, equity structure,
investors and holdings, purchasing and sales data and price lists; and (d) operational and technological
information, including plans, specifications, manuals, forms, templates,
software, designs, methods, procedures, formulas, discoveries, inventions,
improvements, concepts and ideas; and (e) personnel information,
including personnel lists, reporting or organizational structure, resumes,
personnel data, compensation structure, performance evaluations and termination
arrangements or documents.  Proprietary Information also includes
information received in confidence by the Company from its customers or
suppliers or other third parties.

       

      2.           Recognition
of Company’s Rights.  I will not, at
any time, without the Company’s prior written permission, either during or after
my employment, disclose any Proprietary Information to anyone outside of the
Company, or use or permit to be used any Proprietary Information for any purpose
other than the performance of my duties as an employee of the
Company.  I will cooperate with the Company and use my best efforts to
prevent the unauthorized disclosure of all Proprietary Information.  I
will deliver to the Company all copies of Proprietary Information in my
possession or control upon the earlier of a request by the Company or
termination of my employment.

       

      3.           Rights of
Others.  I understand that
the Company is now
and may hereafter be subject to non-disclosure or confidentiality agreements
with third persons which require the Company to protect or refrain from use of
Proprietary Information.  I agree to be bound by the terms of such
agreements in the event I have access to such Proprietary
Information.

       

      4.           Commitment
to Company; Avoidance of Conflict of Interest.  While an employee
of the Company, I
will devote my full-time efforts to the Company’s business and I will not engage
in any other business activity that conflicts with my duties to the
Company.  I will advise the president of the Company (or, if I am an
executive officer of the Company, the Company’s Board of Directors) or his or
her nominee at such time as any activity of either the Company or another
business presents me with a conflict of interest or the appearance of a conflict
of interest as an employee of the Company.  I will take whatever
action is requested of me by the Company to resolve any conflict or appearance
of conflict which it finds to exist.

       

      5.           Developments.  I will make full
and prompt disclosure to the Company of all inventions, discoveries, designs,
developments, methods, modifications, improvements, processes, algorithms,
databases, computer programs, formulae, techniques, trade secrets, graphics or
images, and audio or visual works and other works of authorship (collectively
“Developments”),
whether or not patentable or copyrightable, that are created, made, conceived or
reduced to practice by me (alone or jointly with others) or under my direction
during the period of my employment.  I acknowledge that all work
performed by me is on a “work for hire” basis, and I hereby do assign and
transfer and, to the extent any such assignment cannot be made at present, will
assign and transfer, to the Company and its
successors and assigns all my right, title and interest in all Developments that
(a) relate to the business of the Company or any customer of  the
Company or any of the products or services being researched, developed,
manufactured or sold by the Company or which may be used with such products or
services; or (b) result from tasks assigned to me by the Company; or (c) result
from the use of premises or personal property (whether tangible or intangible)
owned, leased or contracted for by the Company (“Company-Related
Developments”), and all related patents, patent applications, trademarks
and trademark applications, copyrights and copyright applications, and other
intellectual property rights in all countries and territories worldwide and
under any international conventions (“Intellectual Property
Rights”).


      
        
           


        

        
          
          

          
            

          

        

        
           


        

      


      To
preclude any possible uncertainty, I have set forth on Exhibit A attached
hereto a complete list of Developments that I have, alone or jointly with
others, conceived, developed or reduced to practice prior to the commencement of
my employment with the Company that I consider to be my property or the property
of third parties and that I wish to have excluded from the scope of this
Agreement (“Prior
Inventions”). If disclosure of any such
Prior Invention would cause me to violate any prior confidentiality agreement, I
understand that I am not to list such Prior Inventions in Exhibit A but am only
to disclose a cursory name for each such invention, a listing of the party(ies)
to whom it belongs and the fact that full disclosure as to such inventions has
not been made for that reason.  I have also listed on Exhibit A all patents
and patent applications in which I am named as an inventor, other than those
which have been assigned to the Company (“Other Patent
Rights”).  If no such disclosure is attached, I represent that
there are no Prior Inventions or Other Patent Rights.  If, in the
course of my employment with the Company, I incorporate a Prior Invention into a
Company product, process or machine or other work done for the Company, I hereby
grant to the Company a nonexclusive, royalty-free, paid-up, irrevocable,
worldwide license (with the full right to sublicense) to make, have made,
modify, use, sell, offer for sale and import such Prior
Invention.  Notwithstanding the foregoing, I will not incorporate, or
permit to be incorporated, Prior Inventions in any Company-Related Development
without the Company’s prior written consent.

       

      As
required pursuant to Section 2872 of the California Labor Code, I acknowledge
that the Company has notified me that the provisions of this paragraph 5 do not
apply to an invention which qualifies fully under the provisions of Section 2870
of the California Labor Code.  Specifically, such provisions do not
apply to, and I am not required to transfer to the Company, any invention
developed entirely on my own time without using the Company’s equipment,
supplies, facilities, or trade secret information except for those inventions
that either (a) relate at the time of conception or reduction to practice of the
invention to the Company’s business, or actual or demonstrably anticipated
research or development of the Company; or (b) result from any work performed by
the Employee for the Company.  However, I will also promptly disclose
to the Company any such Developments for the purpose of determining whether they
qualify for such exclusion.  I understand that to the extent this
Agreement is required to be construed in accordance with the laws of any state
which precludes a requirement in an employee agreement to assign certain classes
of inventions made by an employee, this paragraph 5 will be interpreted not to
apply to any invention which a court rules and/or the Company agrees falls
within such classes.  I also hereby waive all claims to any moral
rights or other special rights which I may have or accrue in any Company-Related
Developments.

       

      6.           Documents
and Other Materials.  I will keep and
maintain adequate and current records of all Proprietary Information and
Company-Related Developments developed by me during my employment, which records
will be available to and remain the sole property of the Company at all
times.

       

      All
files, letters, notes, memoranda, reports, records, data, sketches, drawings,
notebooks, layouts, charts, quotations and proposals, specification sheets, or
other written, photographic or other tangible material containing Proprietary
Information, whether created by me or others, which come into my custody or
possession, are the exclusive property of the Company to be used by me only in
the performance of my duties for the Company.  Any property situated
on the Company’s premises and owned by the Company, including without limitation
computers, disks and other storage media, filing cabinets or other work areas,
is subject to inspection by the Company at any time with or without
notice.  In the event of the termination of my employment for any
reason, I will deliver to the Company all files, letters, notes, memoranda,
reports, records, data, sketches, drawings, notebooks, layouts, charts,
quotations and proposals, specification sheets, or other written, photographic
or other tangible material containing Proprietary Information, and other
materials of any nature pertaining to the Proprietary Information of the Company
and to my work, and will not take or keep in my possession any of the foregoing
or any copies.

       

      7.           Enforcement
of Intellectual Property Rights.  I will cooperate
fully with the Company, both during and after my employment with the Company,
with respect to the procurement, maintenance and enforcement of Intellectual
Property Rights in Company-Related Developments.  I will sign, both
during and after the term of this Agreement,  all papers, including
without limitation copyright applications, patent applications, declarations,
oaths, assignments of priority rights, and powers of attorney, which the Company
may deem necessary or desirable in order to protect its rights and interests in
any Company-Related Development.  If the Company is unable, after
reasonable effort, to secure my signature on any such papers, I hereby
irrevocably designate and appoint each officer of the Company as my agent and
attorney-in-fact to execute any such papers on my behalf, and to take any and
all actions as the Company may deem necessary or desirable in order to protect
its rights and interests in any Company-Related Development.

       

      8.           Non-Solicitation.  During my
employment and for a period of twelve (12) months following the termination of
my employment for any reason (the “Restricted Period”),
I will not, directly or indirectly, in any manner, other than for the benefit of
the Company, solicit, entice or attempt to persuade any other employee or
consultant of the Company to leave the services of the Company for any
reason.  I acknowledge and agree that if I violate any of the
provisions of this paragraph 8, the running of the Restricted Period will be
extended by the time during which I engage in such violation(s).

       

      9.           Government
Contracts.  I acknowledge
that the Company may have from time to time agreements with other persons or
with the United States Government or its agencies which impose obligations or
restrictions on the Company regarding inventions made during the course of work
under such agreements or regarding the confidential nature of such
work.  I agree to comply with any such obligations or restrictions
upon the direction of the Company. In addition to the rights assigned under
paragraph 5, I also assign to the Company (or any of its nominees) all rights
which I have or acquired in any Developments, full title to which is required to
be in the United States under any contract between the Company and the United
States or any of its agencies.


      
        
           


        

        
          2

          
            

          

        

        
           


        

      


      10.           Prior
Agreements.  I hereby
represent that, except as I have fully disclosed previously in writing to the
Company, I am not bound by the terms of any agreement with any previous employer
or other party to refrain from using or disclosing any trade secret or
confidential or proprietary information in the course of my employment with the
Company or to refrain from competing, directly or indirectly, with the business
of such previous employer or any other party.  I further represent
that my performance of all the terms of this Agreement as an employee of the
Company does not and will not breach any agreement to keep in confidence
proprietary information, knowledge or data acquired by me in confidence or in
trust prior to my employment with the Company. I will not disclose to the
Company or induce the Company to use any confidential or proprietary information
or material belonging to any previous employer or others.

       

      11.           Remedies
upon Breach.
  I understand that the restrictions contained in this
Agreement are necessary for the protection of the business and goodwill of the
Company and I consider them to be reasonable for such purpose.  Any
breach of this Agreement is likely to cause the Company substantial and
irrevocable damage and therefore, in the event of such breach, the Company, in addition to
such other remedies which may be available, will be entitled to specific
performance and other injunctive relief.

       

      12.           Use of
Voice, Image and Likeness.   I give the
Company permission to use any and all of my voice, image and likeness, with or
without using my name, in connection with the products and/or services of the
Company, for the purposes of advertising and promoting such products and/or
services and/or the Company, and/or for other purposes deemed appropriate by the
Company in its reasonable discretion, except to the extent expressly prohibited
by law.

       

      13.           Publications
and Public Statements.  I will obtain the
Company’s written approval before publishing or submitting for publication any
material that relates to my work at the Company and/or incorporates any
Proprietary Information.  To ensure that the Company delivers a
consistent message about its products, services and operations to the public,
and further in recognition that even positive statements may have a detrimental
effect on the Company in certain securities transactions and other contexts, any
statement about the Company which I create, publish or post during my period of
employment and for six (6) months thereafter, on any media accessible by the
public, including but not limited to electronic bulletin boards and
Internet-based chat rooms, must first be reviewed and approved by an officer of
the Company before it is released in the public domain.

       

      14.           No
Employment Obligation.  I understand that
this Agreement does not create an obligation on the Company or any other
person to continue my employment.  I acknowledge that, unless
otherwise agreed in a formal written employment agreement signed on behalf of
the Company by an authorized officer, my employment with the Company is at will
and therefore may be terminated by the Company or me at any time and for any
reason.

       

      15.           Survival
and Assignment by the Company.  I understand that
my obligations under this Agreement will continue in accordance with its express
terms regardless of any changes in my title, position, duties, salary,
compensation or benefits or other terms and conditions of employment. I further
understand that my obligations under this Agreement will continue following the
termination of my employment regardless of the manner of such termination and
will be binding upon my heirs, executors and administrators.  The
Company will have the right to assign this Agreement to its affiliates,
successors and assigns.  I expressly consent to be bound by the
provisions of this Agreement for the benefit of the Company or any parent,
subsidiary or affiliate to whose employ I may be transferred without the
necessity that this Agreement be resigned at the time of such
transfer.

       

      16.           Disclosure
to Future Employers. I will provide a copy of
this Agreement to any prospective employer, partner or coventurer prior to
entering into an employment, partnership or other business relationship with
such person or entity.

       

      17.           Severability.  In case any
provisions (or portions thereof) contained in this Agreement shall, for any
reason, be held invalid, illegal or unenforceable in any respect, such
invalidity, illegality or unenforceability shall not affect the other provisions
of this Agreement, and this Agreement shall be construed as if such invalid,
illegal or unenforceable provision had never been contained
herein.  If, moreover, any one or more of the provisions contained in
this Agreement shall for any reason be held to be excessively broad as to
duration, geographical scope, activity or subject, it shall be construed by
limiting and reducing it, so as to be enforceable to the extent compatible with
the applicable law as it shall then appear.

       

      18.           Interpretation.  This Agreement
will be deemed to be made and entered into in the State of California, and will
in all respects be interpreted, enforced and governed under the laws of the
State of California.  I hereby agree to consent to personal
jurisdiction of the state and federal courts situated within San Diego County,
California for purposes of enforcing this Agreement, and waive any objection
that I might have to personal jurisdiction or venue in those
courts.


       

      [End of
Text]

       

      
        
          
          

        

        
          3

          
            

          

        

        
          
          

        

      

       

      I
UNDERSTAND THAT THIS AGREEMENT AFFECTS IMPORTANT RIGHTS.  BY SIGNING
BELOW, I CERTIFY THAT I HAVE READ IT CAREFULLY AND AM SATISFIED THAT I
UNDERSTAND IT COMPLETELY.

       

      IN WITNESS WHEREOF, the undersigned has
executed this agreement as a sealed instrument as of the date set forth
below.

      


      
        
          	
                  Signed:

                	 
      	 
      
	 
      	
                  (Employee’s
      full name)

                


        

      

      


      
        
          
            
              	
                      Type or print name:

                    	 
      	 
      	 
      
	
                      Social Security Number:

                    	 
      	 
      	
                      Date:

                    	 
      	 
      


            

          

        

      

       

      
        
           


        

        
          
          

          
            

          

        

        
           


        

      


      EXHIBIT
A


       

      To:         NexMed,
Inc.

       

      From:     ____________________

       

      Date:  _____________________

       

      
        	
                SUBJECT:

              	
                Prior
      Inventions

              


      

       

      The following is a complete list of all
inventions or improvements relevant to the subject matter of my employment by
the Company that have been made or conceived or first reduced to practice by me
alone or jointly with others prior to my engagement by the Company:

       

      No
inventions or improvements

       

      See
below:

       

      _______________________________________________________________

       

      _______________________________________________________________

       

      _______________________________________________________________

       

      Additional
sheets attached

       

      The
following is a list of all patents and patent applications in which I have been
named as an inventor:

       

      None

       

      See
below:

       

      _______________________________________________________________

       

      _______________________________________________________________

       

      _______________________________________________________________